Impact of adding a filter for protection from toxic inhalational compounds to the ventilation circuit of mechanically ventilated patients by Eliezer Be’eri et al.
Be’eri et al. Disaster and Mil Med  (2016) 2:3 
DOI 10.1186/s40696-016-0015-6
RESEARCH ARTICLE
Impact of adding a filter for protection 
from toxic inhalational compounds to the 
ventilation circuit of mechanically ventilated 
patients
Eliezer Be’eri1, Simon Owen1, Mark Shachar2, Yaron Barlavie3 and Arik Eisenkraft4,5,6*
Abstract 
Background: Standard-issue Chemical-Biological-Radio-Nuclear (CBRN) gasmasks, as used for protection from 
non-conventional warfare agents or toxic industrial compounds, cannot be used by ventilated patients, leaving them 
exposed to toxic agents inhaled via their ventilators. This study was conducted to determine the safety of a CBRN filter 
added to the patient circuit of a ventilator, as a method for affording inhalational protection to ventilated patients.
Methods: A Landrace pig was ventilated sequentially with 3 types of ventilators according to 17 different ventilation 
protocols, with and without a CBRN filters added in-line to the ventilation tubing for each protocol. For each protocol, 
physiological parameters, including oxygen saturation, inspired CO2, end tidal CO2, inspired oxygen, respiratory rate, 
and pulse rate, as well as airflow parameters including peak inspiratory pressure, positive end expiratory pressure and 
tidal volume were measured. The impact on the ventilator’s trigger/sensitivity function was evaluated in vitro using a 
Michigan test lung.
Results: On average, the addition of the CBRN filter resulted in a 16 ml (5 %) decrease (range 0–50 ml) in the tidal 
volume, a 1.7 cm H2O (10 %) decrease (range 1–3 cm H2O) in the peak inspiratory pressure, and a 0.1 cm H2O (3 %) 
decrease (range 0–1 cm H2O) in the positive end expiratory pressure delivered to the animal. Some ventilators com-
pensated for these airflow changes while others did not, depending on the design of the ventilator’s pressure/flow 
sensing mechanism. Significant rebreathing occurred when the filter was positioned directly on the animal’s endotra-
cheal tube, but not when positioned on the air outflow port of the ventilator. In vitro measurements showed that the 
addition of the CBRN filter added a mean pressure gradient of 0.45 cm H2O to the trigger/sensitivity function of the 
system.
Conclusions: In-line addition of a CBRN filter to ventilation tubing is a feasible strategy for affording inhalational 
protection to ventilated patients.
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Background
Dispersion of volatile Toxic Industrial Compounds 
(TICs) presents a major threat to nearby residents. A 
scenario of volatile TIC dispersion may occur due to an 
industrial accident, or as a result of an act of terrorism 
[1–10]. Protection against TIC exposure can be afforded 
by wearing a standard issue gasmask, which provides 
respiratory protection by filtering inspired air through 
a standard Chemical-Biological-Radio-Nuclear (CBRN) 
filter that removes toxic agents by adsorbance and 
absorbance into activated charcoal in the filter [11, 12]. 
Mechanically ventilated patients, however, are a sub-
group for whom standard CBRN gasmasks worn on the 
face would not provide protection from TICs, because 
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in an environment contaminated with TICs an exposed 
ventilator would intake contaminated air and transmit 
it directly to the patient via the ventilation circuit and 
patient interface (regardless of whether the interface is an 
endotracheal tube, a tracheostomy cannula or a nonin-
vasive facemask), without flowing through a CBRN filter 
along the way. A potential vulnerability to TIC expo-
sure thus exists for patients who are ventilated on any 
machine that intakes atmospheric air. This would include 
home ventilators that intake air directly from the sur-
rounding environment; ICU or anesthesia ventilators that 
operate on compressed air from a central air compressor 
(where the air compressor itself might be exposed to con-
taminated air); and ventilators that blend compressed air 
or oxygen (such as from an oxygen cylinder) with ambi-
ent air. In addition, for many patients who use ventilatory 
support only part-time—such as neuromuscular patients 
on nighttime facemask ventilation—wearing a CBRN 
gasmask while not on the ventilator might not be a real-
istic method for TIC protection, because the increased 
resistance to inspiration caused by the CBRN filter might 
not be tolerable for patients in chronic respiratory failure, 
especially at a time of psychological stress and concomi-
tant increased respiratory rate. Although a limited num-
ber of ventilators have been custom designed to enable 
attachment of a CBRN filter to the ventilator’s air intake 
port for filtering of TICs [13], the majority of home and 
hospital ventilators currently in use do not have this 
design feature. To the best of our knowledge, no effective 
solutions for these ventilated patients in an event of vola-
tile TIC dispersion have been reported in the literature. 
The current study was therefore aimed at developing a 
single standardized, universally applicable solution for 
TIC protection for all mechanically ventilated patients, 
in both the home and hospital settings, regardless of the 
type of ventilator being used.
The following possible solutions for ventilated patients 
were initially considered: attaching a CBRN filter to the 
air intake port of the ventilator, enclosing the patient and 
the ventilator in a gas-proof tent, and attaching the ven-
tilator air intake port to a cylinder of compressed air or 
oxygen, which would be closed to the environment.
Preliminary experiments showed that adapting CBRN 
filters to cover the air intake ports of ventilators was not a 
feasible mass solution, because the configurations of air-
intake ports differ between different ventilator models, 
for some of which it was impossible to attach a CBRN fil-
ter in a way that would reliably prevent contaminated air 
from entering. Gas-proof tents are prohibitively expen-
sive, and erecting them is labor-intensive, making them, 
too, an unrealistic mass solution for all ventilated patients 
[14]. In addition, use of such tents is not feasible in ICUs, 
where rapid and unhindered access to the ventilated 
patient is essential at all times. Nor are such tents suit-
able for use in chronic-care and rehabilitation facilities, 
where a single member of staff may be responsible for, 
and therefore need repeated access to, several patients 
simultaneously. Cylinders of compressed gas were found 
to be appropriate for ICU ventilators that operate on 
compressed air, but not for home ventilators that draw in 
room air; moreover, this solution would only be effective 
for a limited period of time, until the contents of the cyl-
inder ran out.
We therefore determined that the only practical, afford-
able and universally applicable solution to the problem of 
CBRN protection for ventilated patients during a TIC 
dispersion incident would be to attach a CBRN filter not 
to the air-intake port of each ventilator, but to the air-
outflow port. This would ensure that even if the ventila-
tor itself was contaminated, all air reaching the patient 
would be adequately filtered of contaminants; in addition, 
this solution would ensure that the period of time during 
which a ventilator could operate during suspected expo-
sure to the toxic compounds would be practically unlim-
ited, and that caregivers would have unhindered access to 
the ventilated patient at all times. Since the diameter of 
air-outflow ports on all ventilators conforms to a univer-
sal 22  mm standard, mass-production of a CBRN filter 
that would fit onto the air-outflow port of any model of 
ventilator in an airtight manner would be both possible 
and inexpensive.
The solution of attaching a CBRN filter to the air-out-
flow port of a ventilator, however, raised concerns that 
the increased resistance to airflow caused by the filter 
might impact adversely on the efficacy of the patient’s 
ventilation. For this reason, we elected to evaluate the 
safety, in an animal model, of adding a CBRN filter to the 
air-outflow tract of standard mechanical ventilators.
Methods
Animal study
A standard M-80 CBRN filter (Shalon Industries, Kiryat 
Gat, Israel) was customized to fit standard 22 mm diam-
eter ventilation tubing (Fig.  1). The M-80 filter is com-
monly issued to both civilians and military personnel 
in Israel, and is in compliance with generally accepted 
volume and resistance standards worldwide. A healthy 
30  kg Landrace pig was anesthetized with a combina-
tion of Diazepam and Ketamine, and intubated with a 
7 mm endotracheal tube. The animal was then ventilated 
using three different models of ventilators representing 
typical examples of home and ICU ventilators in Israel 
(Synchrony, Respironics Inc, Murraysville PA; iVent, Ver-
samed Ltd, Israel; and LTV-1000, Pulmonetic Systems, 
Minneapolis MN), and 17 different ventilation protocols 
that were designed to be representative of typical home 
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and ICU ventilation settings (Table 1). For each ventilator 
model and ventilation protocol, the animal was ventilated 
first without, and then with, a CBRN filter added in-line 
to the ventilation tubing. Physiological indices (oxygen 
saturation, inspired CO2 [FiCO2], end tidal CO2 [etCO2], 
inspired oxygen [FiO2], respiratory rate [RR], and heart 
rate [HR]) and airflow parameters (peak inspiratory 
pressure [PIP], positive end expiratory pressure [PEEP], 
and tidal volume [TV]) were measured with and with-
out the CBRN filter in place. Protocols 1 through 3 used 
volume cycled ventilation, protocols 4 through 6 used 
time-cycled pressure-limited ventilation, and protocols 
7 through 12 used flow-cycled (pressure support) ven-
tilation, as typically supplied by bilevel ventilators. For 
ventilation protocols 1 through 12 the CBRN filter was 
positioned between the ventilator and the animal’s res-
piratory circuit (Fig. 1). This was assumed to be the ideal 
positioning for the CBRN filter, as it achieves CBRN fil-
tration of all inspiratory gas flow, without impacting on 
expiratory gas flow at all. However, so as to evaluate the 
potential physiological impact of the CBRN filter when 
exposed to expiratory airflow, in protocols 13 through 16, 
using time-cycled pressure-limited ventilation, the CBRN 
filter was positioned between the animal’s respiratory 
circuit and endotracheal tube, such that both inspiratory 
and expiratory gas flow passed through the filter (Fig. 2). 
Between changes in protocols 1 through 16, and after 
addition or removal of the CBRN filter, the animal was 
allowed to stabilize for 3–5 min before physiological and 
airflow measurements were made. So as to evaluate the 
potential impact of a longer period of ventilation through 
an CBRN filter, in protocol number 17 volume-cycled 
ventilation through a CBRN filter was maintained unin-
terrupted for 30 min before physiological measurements 
were recorded.
Fig. 1 CBRN filter attached to the air-outflow port of a home ventila-
tor
Table 1 Ventilation protocols used
a CBRN filter mounted on air outflow port of ventilator
b CBRN filter mounted on endotracheal tube




Make of ventilator Mode Cycling mechanism Parameters Notes
1 Pulmonetic LTV-1000 Assist-control Volume TV = 275, PEEP = 4, rate = 20, Ti = 1 a
2 Pulmonetic LTV-1000 Assist-control Volume TV = 320, PEEP = 4, rate = 20, Ti = 1 a
3 Pulmonetic LTV-1000 Assist-control Volume TV = 400, PEEP = 4, rate = 20, Ti = 1 a
4 Versamed iVent Assist-control Time (pressure limited) PIP = 15, PEEP = 5, rate = 20, Ti = 1 a
5 Versamed iVent Assist-control Time (pressure limited) PIP = 20, PEEP = 5, rate = 20, Ti = 1 a
6 Versamed iVent Assist-control Time (pressure limited) PIP = 25, PEEP = 5, rate = 20, Ti = 1 a
7 Respironics BiPAP Synchrony Spontaneous-timed Flow (pressure support) PIP = 10, PEEP = 5, Ti = 1.4, rate = 20 a
8 Respironics BiPAP Synchrony Spontaneous-timed Flow (pressure support) PIP = 15, PEEP = 5, Ti = 1.4, rate = 20 a
9 Respironics BiPAP Synchrony Spontaneous-timed Flow (pressure support) PIP = 20, PEEP = 5, Ti = 1.4, rate = 20 a
10 Respironics BiPAP Synchrony Spontaneous-timed Flow (pressure support) PIP = 15, PEEP = 4, Ti = 1.4 a
11 Respironics BiPAP Synchrony Spontaneous-timed Flow (pressure support) PIP = 15, PEEP = 6, Ti = 1.4 a
12 Respironics BiPAP Synchrony Spontaneous-timed Flow (pressure support) PIP = 15, PEEP = 8, Ti = 1.4 a
13 Versamed iVent Assist-control Time (pressure limited) PIP = 10, PEEP = 5, rate = 20, Ti = 1 b
14 Versamed iVent Assist-control Time (pressure limited) PIP = 15, PEEP = 5, rate = 20, Ti = 1 b
15 Versamed iVent Assist-control Time (pressure limited) PIP = 20, PEEP = 5, rate = 20, Ti = 1 b
16 Versamed iVent Assist-control Time (pressure limited) PIP = 25, PEEP = 5, rate = 20, Ti = 1 b
17 Versamed iVent Assist-control Volume TV = 260, PEEP = 4, rate = 20, Ti = 1 c
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Throughout the trial the animal’s state of anesthesia 
was maintained at a level that prevented the animal from 
actively opposing mechanical ventilation, and all physi-
ological measurements were made with the animal sta-
ble on room air without supplemental oxygen. The trial 
was approved by the Animal Care Committee of Ram-
bam Medical Center and was conducted at the Animal 
Research Laboratory of the Technion Medical School/
Rambam Medical Center in Haifa, Israel. Animal care 
and handling were in accordance with the National Insti-
tute of Health guidelines for ethical animal research.
In vitro study
Since the impact of a CBRN filter on a ventilator’s trig-
ger/sensitivity function (i.e., the negative pressure or flow 
that a patient has to develop spontaneously so as to trig-
ger a mechanical breath from the ventilator) cannot be 
evaluated on an anesthetized animal that is not breathing 
spontaneously, this parameter was studied in vitro. First, 
the resistance versus flow characteristics of a standard-
issue CBRN filter were measured empirically using a 
Windjammer 5.1 inch blower (Amatek Inc. Kent, OH) 
and an IMT PF300 Flow Analyzer (IMT Medical, Buchs, 
Switzerland). Then, a Michigan test lung and a Synchrony 
ventilator set to deliver PEEP at levels of 5, 7 and 9 cm 
H2O were used to evaluate the impact of the CBRN filter 
on the ventilator’s trigger/sensitivity function. Spontane-
ous inspiratory effort was simulated by randomly gener-
ating brief episodes of negative pressure within the test 
lung at each of the PEEP values. The negative-pressure 
waveform that propagated into the ventilation tubing as a 
result was recorded by two pressure-flow sensors (Y Flow 
Transducer, Versamed Ltd., Israel) connected in-line 
between the test lung and the ventilator. The pressure 
gradient between the sensors was measured first without 
the CBRN filter in situ, and thereafter with the CBRN fil-
ter inserted between the two sensors. The pressure gra-
dient between the pressure-flow sensors was measured 
using SV Monitor software. The internal volume of the 




The animal was ventilated for a total of six and a half 
hours, for approximately half of which the CBRN fil-
ter was in  situ. Table  2 shows the airflow parameters 
measured for each ventilation protocol. On average, 
Fig. 2 CBRN Filter positioned between an endotracheal tube and the 
respiratory circuit of a home ventilator
Table 2 Change in air-flow parameters caused by addition 
of CBRN filter to circuit
a Volume cycled ventilation with CBRN filter on air outflow port of ventilator
b Time cycled pressure limited ventilation with CBRN filter on air outflow port of 
ventilator
c Flow cycled ventilation with CBRN filter on air outflow port of ventilator







Loss of TV ml 
(%)
Notes
1 3 (25) 0 a
2 1 (7) −1 (−20) a
3 3 (15) 0 a
4 0 0 10 (3) b
5 1 (5) 0 40 (10) b
6 3 (12) 0 50 (11) b
7 1 (10) 0 10 (7) c
8 1 (7) 0 30 (10) c
9 2 (10) 1 (20) 20 (5) c
10 1 (8) 1 (25) 30 (9) c
11 1 (7) 0 20 (7) c
12 1 (7) 0 10 (5) c
13 1 (8) 0 10 (5) d
14 2 (11) 0 0 d
15 3 (12) 0 −10 (−2) d
16 3 (10) 1 (20) −10 (−2) d
Mean = 1.7 (10) Mean = 0.1 (3) Mean = 16.2 (5)
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positioning the CBRN filter in the ventilation circuit 
resulted in a 16 ml (5 %) decrease in tidal volume (range 
0–50 ml), a 1.7 cm H2O (10 %) decrease in peak inspir-
atory pressure (range 1–3  cm H2O), and a 0.1  cm H2O 
(3  %) decrease in PEEP across the filter (range 0–1  cm 
H2O). The way that the ventilators responded to the 
changes caused by addition of the CBRN filter to the ven-
tilation circuit depended on the design of the ventilator’s 
pressure sensor. The Synchrony machine has an internal 
pressure/flow sensor located within the ventilator. For 
this reason, in protocols in which the CBRN filter was 
positioned on the gas outflow port of the Synchrony ven-
tilator (protocols 7–12), the filter was “downstream” from 
the ventilator’s pressure/flow sensor. In these instances, 
the ventilator did not sense or compensate for the pres-
sure/volume drop-off across the filter after the filter was 
added. The animal consequently received somewhat 
less ventilation with the filter in  situ than without. In 
contrast, the pressure/flow sensor of iVent and LTV 
machines is located at the far end of the ventilation tub-
ing, close to the patient. For this reason, the CBRN filter 
positioned on the gas outflow port of these ventilators 
(protocols 1–6 and 13–17) was “upstream” from the 
ventilator’s pressure/flow sensor, enabling the ventilator 
to sense and compensate for the pressure/volume drop-
off caused by the addition of the filter. The animal thus 
continued to receive the same degree of ventilation even 
after the addition of the filter.
Addition of a filter between the ventilator and the res-
piratory circuit (protocols 1–12 and protocol 17) did not 
cause any detectable deterioration in the animal’s respira-
tory physiology (saturation, etCO2, RR and HR remained 
constant), and there was no evidence of rebreathing (no 
change in FiO2 or FiCO2). However, when the CBRN 
filter was positioned between the respiratory circuit 
and the endotracheal tube (protocols 13 through 16), 
evidence of rebreathing emerged within 1  min: FiCO2 
increased to 1 %, FiO2 decreased to 17 %, and oxygen sat-
uration decreased to less than 90 %.
In vitro study
The resistance versus flow characteristics of the CBRN fil-
ter as measured empirically is presented in Fig. 3. Table 3 
shows the impact of the CBRN filter on the trigger/sensi-
tivity function of a Synchrony ventilator. The table shows 
the negative-pressure (“trigger”) gradient generated by 
the Michigan test lung, as measured by two pressure-flow 
sensors positioned between the test lung and the venti-
lator. The negative pressure inspiratory flow generated 
by each of the simulated inspiratory efforts (i.e. prior to 
the onset of positive pressure airflow from the ventila-
tor) ranged from 1 to 5 L/min. Without the filter in situ, 
the intrinsic resistance of the sensors resulted in a mean 
pressure gradient of 0.14  cm H2O between them. After 
insertion of the filter between the sensors, generation of 
negative pressure spikes in the test lung showed a mean 
pressure gradient of 0.59  cm H2O (range 0.19–1.39  cm 
H2O) across the filter. Ignoring the intrinsic resistance of 
the sensors, the filter generated a mean pressure gradient 
of 0.45 cm H2O, a one-third drop-off in trigger pressure. 
The internal volume of the CBRN filter, representing the 
dead space added to the respiratory airflow pathway by 
addition of the filter, was measured as being 140 ml.
Discussion
Manufacturing and chemical plants may pose environ-
mental hazards to nearby residents, due to either acci-
dents or malpractice [1–10]. In addition, in the current 
era biological and chemical TICs have been used in war-
fare and acts of terrorism. Ventilated patients in institu-
tions and ambulatory settings may thus be affected by 
TICs. Nevertheless, current protective protocols do not 
provide an adequate solution for this population. In this 
Fig. 3 Resistance vs flow of a standard-issue CBRN filter



















Mean: −1.84 Mean: −1.24 Mean: 0.59
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study, the safety of a standard CBRN filter added in-line 
to the ventilation circuit of an animal model was tested. 
We show that the addition of a CBRN filter is safe, well 
tolerated physiologically, and has minimal impact on air-
flow parameters. It is suggested that this solution may be 
a useful method for protecting ventilated patients in all 
settings from TICs.
We are aware of several limitations to this study. Tech-
nical constraints prevented us from evaluating the loss 
of tidal volume across the CBRN filter under conditions 
of volume-cycled ventilation. Changes in this parameter, 
however, are unlikely to differ from those found under 
conditions of time-cycled and flow-cycled ventilation. 
In addition, inspiratory time was not measured, as this 
parameter was fixed for all the ventilation protocols used 
in the trial and thus would not change with the addition 
of a CBRN filter to the ventilation circuit.
Application of this technique on a mass scale may 
require several precautions in order to minimize the 
risk of harm being caused to the patient by the filter. It 
is important to ensure that the CBRN filter is positioned 
directly on the air outflow port of the ventilator, and not 
on the patient’s tracheostomy or endotracheal tube, as 
this will lead to dangerous rebreathing of exhaled CO2, 
most likely due to accumulation of CO2 in the dead space 
of the CBRN filter. Although off-gassing (i.e. second-
hand exposure to toxins in air exhaled from a contami-
nated patient) is a concern for caregivers treating patients 
exposed to nerve agents, and positioning the CBRN filter 
directly on the patient’s endotracheal tube might provide 
some protection against this, for most TICs this is not a 
real concern, and the danger to the patient of hypercap-
nia from rebreathing far outweighs the theoretical ben-
efit of minimizing off-gassing by placing the CBRN filter 
directly on the endotracheal tube.
For ventilators with an externally located pressure/flow 
sensor, such as most volume-cycled and time-cycled ven-
tilators, no readjustment of tidal volume or PIP should be 
necessary after addition of a CBRN filter to the ventila-
tion circuit, provided the CBRN filter is correctly posi-
tioned on the ventilator outflow port, “upstream” from 
the pressure/flow sensor. However, for ventilators with an 
internally located pressure/flow sensor, such as bi-level 
ventilators, it may be advisable to increase the inspira-
tory positive airway pressure (IPAP) by 2 cm H2O so as 
to compensate for potential pressure drop-off after addi-
tion of a CBRN filter. Although some patients on home 
ventilation will be able to perform such an adjustment 
competently and safely, and will remember to return 
the ventilator settings to their baseline after removal of 
the CBRN filter, the potential for error on the part of 
less aware home ventilated patients is real, particularly 
during a time of high stress and anxiety. For this reason, 
public health authorities should consider whether or not 
adequate education of this population is feasible before 
issuing a general recommendation to change the param-
eters of bi-level ventilators when attaching a CBRN filter. 
It may be more prudent to recommend that healthcare 
workers make such changes, wherever possible, while 
advising patients not to adjust their ventilator settings 
themselves.
Patients breathing spontaneously should be advised 
that the addition of the filter may cause a sensation of 
increased effort of breathing, due to the increase in 
resistance to trigger flow caused by the CBRN filter. This 
may necessitate increasing the mandatory number of 
breaths delivered by the ventilator per minute as a means 
of compensation. In addition, the sensation of increased 
resistance to initiating a breath that is caused by the addi-
tion of a CBRN filter may be mitigated in part by increas-
ing the patient’s PEEP setting or adjusting the sensitivity 
of the ventilator’s trigger function.
Both public health authorities and patients should be 
informed as to the recommended duration of use of a 
CBRN filter once it has been unsealed and inserted 
into the patient’s ventilation circuit. When exposed to 
the TIC ambient air concentrations that are typically 
encountered in industrial accidents or acts of terror, 
CBRN filters provide adequate protection for a mini-
mum of 8  h, at all clinically used ventilation minute 
volumes. There is therefore no need to replace the fil-
ter prior to that, and it is highly unlikely that a single 
TIC exposure incident would last longer than that time-
frame. However, in the event of prolonged exposure 
beyond 8  h, a new filter should be inserted as soon as 
is feasible thereafter. If a new filter has been opened 
but not exposed to active airflow, it can be resealed 
and stored for up to 12 months without loss of efficacy. 
Although addition of a CBRN filter to a patient’s ven-
tilation circuit protects the patient from inhaling TICs, 
the patient remains exposed to these agents through 
his mucous membranes. For this reason, patients being 
ventilated via a tracheostomy should wear a standard 
gasmask to protect the mucous membranes of their 
eyes, nose and mouth, in addition to adding a CBRN fil-
ter to their ventilation tubing. This may not be feasible, 
however, for patients being ventilated via an endotra-
cheal tube or facemask.
Another concern is that of a possible exothermic 
reaction between the charcoal of the CBRN filter and 
enriched oxygen, which is commonly used by venti-
lated patients. This was tested separately in a study that 
showed no such reaction, and that oxygen flow through a 
CBRN filter is safe [15].
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Conclusions
In-line addition of a CBRN filter to the ventilation circuit 
represents a feasible strategy for affording inhalational 
protection from toxic inhalational compounds to the 
general population of home and ICU ventilated patients. 
Further clinical studies are necessary to confirm these 
findings.
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